Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer.
Tian S, Xu M, Geng X, Fang J, Xu H, Xue X, Hu H, Zhang Q, Yu D, Guo M, Zhang H, Lu J, Guo C, Wang Q, Liu S, Zhang W.
Tian S, et al. Among authors: xu m, xu h.
Adv Sci (Weinh). 2024 Nov 5:e2410285. doi: 10.1002/advs.202410285. Online ahead of print.
Adv Sci (Weinh). 2024.
PMID: 39499771